Cross-cultural perspectives on noninvasive prenatal testing
Prenatal Diagnostic Testing for Genetic Disorders: The revolution of the Non-Invasive Prenatal Test, Page: 379-388
2023
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Following its introduction to the market in 2011, the rapid spread of noninvasive prenatal testing (NIPT) was driven by commercial developers of the technology. The numerous benefits it offers are recognized by users and clinicians, but its introduction also raises several concerns regarding ethical, social, legal, and policy implications. This chapter describes the NIPT implementation in three countries: China, Canada, and Lebanon. These countries are selected since they represent a diversity of cultural frameworks and healthcare system structures. We discuss each country's healthcare system, NIPT offer and coverage, financial and organizational resources, and cultural and policy contexts with respect to disability and pregnancy termination. The comparison of these factors across the three countries illustrates how the implementation of NIPT is shaped by cultural values and socioeconomic contexts. It also reveals the importance of some key universal ethical requirements for the responsible implementation of NIPT in any cultural context.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85196238382&origin=inward; http://dx.doi.org/10.1007/978-3-031-31758-3_24; https://link.springer.com/10.1007/978-3-031-31758-3_24; https://dx.doi.org/10.1007/978-3-031-31758-3_24; https://link.springer.com/chapter/10.1007/978-3-031-31758-3_24
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know